Disposable Hypodermic needles
- UID
- IMP/MD/2020/000139_5c1642fb7938f4b976d21e6da73d9a6c_08b040460d337cf6f3837ae9294e57e0
- Device class
- Class B
- Brand name
- NovoFine Plus 32G needles
- License holder
- M/s Novo Nordisk India Pvt Ltd
- Approving authority
- CDSCO
- Product information
- NovoFine® Plus needles having a thread interface are intended for use with needle-based pen injectors for the subcutaneous injection of drugs, including insulin, GLP-1 and growth hormone products. Indications for use NovoFine® Plus needles are indicated for use with needle-based pen injectors, like NovoPen® 4, NovoPen Echo® and NovoPen® 5 as well as FlexPen® and FlexTouch®, i.e. both durable and prefilled pen injectors for treatment of diabetes and growth hormone deficiency.
Disposable Hypodermic needles is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000139_5c1642fb7938f4b976d21e6da73d9a6c_08b040460d337cf6f3837ae9294e57e0. This device is marketed under the brand name NovoFine Plus 32G needles. The license holder is M/s Novo Nordisk India Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.